4.6 Article

Are there ethnic and religious variations in uptake of bowel cancer screening? A retrospective cohort study among 1.7 million people in Scotland

Journal

BMJ OPEN
Volume 10, Issue 10, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2020-037011

Keywords

gastrointestinal tumours; public health; health policy; preventive medicine

Funding

  1. Chief Scientist's Office [CZH/4/878]
  2. Cancer Research UK [C3743/A16594]
  3. NHS Health Scotland

Ask authors/readers for more resources

Objective Cancer screening should be equitably accessed by all populations. Uptake of colorectal cancer screening was examined using the Scottish Health and Ethnicity Linkage Study that links the Scottish Census 2001 to health data by individual-level self-reported ethnicity and religion. Setting Data on 1.7 million individuals in two rounds of the Scottish Bowel Cancer Screening Programme (2007-2013) were linked to the 2001 Census using the Scottish Community Health Index number. Main outcome measure Uptake of colorectal cancer screening, reported as age-adjusted risk ratios (RRs) by ethnic group and religion were calculated for men and women with 95% CI. Results In the first, incidence screening round, compared with white Scottish men, Other White British (RR 109.6, 95% CI 108.8 to 110.3) and Chinese (107.2, 95% CI 102.8 to 111.8) men had higher uptake. In contrast, men of all South Asian groups had lower uptake (Indian RR 80.5, 95% CI 76.1 to 85.1; Pakistani RR 65.9, 95% CI 62.7 to 69.3; Bangladeshi RR 76.6, 95% CI 63.9 to 91.9; Other South Asian RR 88.6, 95% CI 81.8 to 96.1). Comparable patterns were seen among women in all ethnic groups, for example, Pakistani (RR 55.5, 95% CI 52.5 to 58.8). Variation in uptake was also observed by religion, with lower rates among Hindu (RR (95%CI): 78.4 (71.8 to 85.6)), Muslim (69.5 (66.7 to 72.3)) and Sikh (73.4 (67.1 to 80.3)) men compared with the reference population (Church of Scotland), with similar variation among women: lower rates were also seen among those who reported being Jewish, Roman Catholic or with no religion. Conclusions There are important variations in uptake of bowel cancer screening by ethnic group and religion in Scotland, for both sexes, that require further research and targeted interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening

Lasse Kaalby, Issam Al-Najami, Ulrik Deding, Gabriele Berg-Beckhoff, Robert J. C. Steele, Morten Kobaek-Larsen, Aasma Shaukat, Morten Rasmussen, Gunnar Baatrup

Summary: This study found that screening participants with detectable fecal hemoglobin had higher mortality rates and different causes of death compared to those without. Fecal hemoglobin may serve as a marker for diseases not directly related to colorectal cancer and may be targeted for preventive measures in the future.

CANCERS (2022)

Letter Public, Environmental & Occupational Health

Response to Editorial: 'Risk or chance'

Bob Steele

JOURNAL OF MEDICAL SCREENING (2022)

Article Medical Laboratory Technology

Faecal haemoglobin concentration in adenoma, before and after polypectomy, approaches the ideal tumour marker

Craig Mowat, Jayne Digby, Shirley Cleary, Lynne Gray, Pooja Datt, David R. Goudie, Robert J. C. Steele, Judith A. Strachan, Adam Humphries, Callum G. Fraser

Summary: Quantitative FIT can serve as a good tumor marker in post-polypectomy surveillance, reducing the need for colonoscopy and minimizing potential risks for patients.

ANNALS OF CLINICAL BIOCHEMISTRY (2022)

Article Gastroenterology & Hepatology

Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Anna Forsberg, Marcus Westerberg, Chris Metcalfe, Robert Steele, Johannes Blom, Lars Engstrand, Kaisa Fritzell, Mikael Hellstrom, Lars-Ake Levin, Christian Lowbeer, Andreas Pischel, Ulf Stromberg, Sven Tornberg, Yvonne Wengstrom, Anders Ekbom, Lars Holmberg, Rolf Hultcrantz

Summary: This study aimed to investigate the impact of once-only colonoscopy or two rounds of faecal immunochemical test screening on colorectal cancer mortality and incidence. The study found differences in the detection rates of colorectal cancer and advanced adenomas between the colonoscopy group and the faecal immunochemical test group, but both screening methods had a low number of adverse events.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Medical Laboratory Technology

Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening

Gavin R. C. Clark, Robert J. C. Steele, Callum G. Fraser

Summary: Women are at a disadvantage in colorectal cancer screening due to lower faecal haemoglobin concentrations, leading to poorer outcomes. Risk scoring strategies that consider sex have not been extensively tested or introduced. Governments and agencies should prioritize allocating resources to implement simple strategies, such as using different haemoglobin thresholds, to achieve equal positivity in both sexes.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2022)

Article Gastroenterology & Hepatology

Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)

Kevin J. Monahan, Michael M. Davies, Muti Abulafi, Ayan Banerjea, Brian D. Nicholson, Ramesh Arasaradnam, Neil Barker, Sally Benton, Richard Booth, David Burling, Rachel Victoria Carten, Nigel D'Souza, James Edward East, Jos Kleijnen, Michael Machesney, Maria Pettman, Jenny Pipe, Lance Saker, Linda Sharp, James Stephenson, Robert J. C. Steele

Summary: Faecal immunochemical testing (FIT) has high sensitivity for detecting colorectal cancer (CRC). This guideline aims to provide a clear strategy for using FIT in the diagnostic pathway of people with signs or symptoms of a suspected CRC diagnosis. The guideline was developed by a multidisciplinary group and includes evidence-based recommendations and research priorities.
Article Public, Environmental & Occupational Health

Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme

Gavin R. C. Clark, Callum G. Fraser, Judith A. Strachan, Robert J. C. Steele

Summary: This study explores the variation of faecal haemoglobin concentrations (f-Hb) in different rounds of a colorectal cancer (CRC) screening programme and its relation to colonoscopy findings using data from the Scottish Bowel Screening Programme (SBoSP). The study finds that the profiles of f-Hb differ in individuals with a negative FIT result and those with neoplastic pathology. However, the difference between profiles in those with a negative colonoscopy is similar to that in those with an adenoma. Furthermore, the risk of CRC diagnosis in the second round after a negative colonoscopy is not significantly different from that after a negative test result.

JOURNAL OF MEDICAL SCREENING (2022)

Article Medicine, General & Internal

Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening

Lasse Kaalby, Ulrik Deding, Issam Al-Najami, Gabriele Berg-Beckhoff, Thomas Bjorsum-Meyer, Tinne Laurberg, Aasma Shaukat, Robert J. C. Steele, Anastasios Koulaouzidis, Morten Rasmussen, Morten Kobaek-Larsen, Gunnar Baatrup

Summary: New research suggests that faecal haemoglobin concentration (f-Hb) can indicate the presence of serious diseases not related to colorectal cancer (CRC). This study found an association between increasing f-Hb and the risk of mortality, as well as an increased risk of dying from respiratory disease, cardiovascular disease, and other cancers. f-Hb may be a potential biomarker for non-CRC diseases.

BMC MEDICINE (2023)

Article Nutrition & Dietetics

An evaluation of the feasibility of implementing the BeWEL lifestyle intervention programme for people at increased risk of colorectal cancer - from research to real life

Annie S. Anderson, Claire Donaghy, Ross Lamb, Robert J. C. Steele, Susan Moug

Summary: The BeWEL trial showed that a significant proportion of colorectal adenoma patients are interested in lifestyle interventions and achieved clinically relevant weight loss at 12-month follow-up. However, replicating the program in a non-research setting was found to be less feasible, and alternative approaches should be explored.

JOURNAL OF HUMAN NUTRITION AND DIETETICS (2023)

Article Oncology

Faecal haemoglobin concentration predicts all-cause mortality

Ulrik Deding, Lasse Kaalby, Robert Steele, Issam Al-Najami, Morten Kobaek-Larsen, Eva Plantener, Jeppe B. Madsen, Jonna S. Madsen, Thomas Bjorsum-Meyer, Gunnar Baatrup

Summary: Population-based screening for colorectal cancer using FIT is recommended. Detectable faecal haemoglobin can indicate colorectal neoplasia as well as other conditions. A positive FIT predicts an increased risk of death from colorectal cancer but might also predict an increased risk of all-cause mortality.

EUROPEAN JOURNAL OF CANCER (2023)

Article Public, Environmental & Occupational Health

Sex variation in colorectal cancer mortality: trends and implications for screening

Gavin R. C. Clark, Callum G. Fraser, Judith A. Strachan, Robert J. C. Steele

Summary: Colorectal cancer (CRC) screening using faecal tests reduces disease-specific mortality. This study examined mortality rates and its association with sex before and after CRC screening in Scotland. The results showed that CRC mortality declined from 1990 to 2020, but the decline differed between sexes, indicating a larger beneficial effect of screening on CRC mortality in men compared to women.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2023)

Article Public, Environmental & Occupational Health

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme

Jayne Digby, Callum G. Fraser, Gavin Clark, Craig Mowat, Judith A. Strachan, Robert J. C. Steele

Summary: This study aimed to develop a risk-scoring model for colorectal cancer using data from the Scottish Bowel Screening Programme. Only faecal haemoglobin concentration and age showed a significant association with colorectal cancer. By tailoring the threshold for faecal haemoglobin concentration according to age, the disparity in interval cancer proportion between women and men could be reduced.

JOURNAL OF MEDICAL SCREENING (2023)

Article Gastroenterology & Hepatology

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

Robert S. Bresalier, Carlo Senore, Graeme P. Young, James Allison, Robert Benamouzig, Sally Benton, Patrick M. M. Bossuyt, Luis Caro, Beatriz Carvalho, Han-Mo Chiu, Veerle M. H. Coupe, Willemijn de Klaver, Clasine Maria de Klerk, Evelien Dekker, Sunil Dolwani, Callum G. Fraser, William Grady, Lydia Guittet, Samir Gupta, Stephen P. Halloran, Ulrike Haug, Geir Hoff, Steven Itzkowitz, Tim Kortlever, Anastasios Koulaouzidis, Uri Ladabaum, Beatrice Lauby-Secretan, Marcis Leja, Bernard Levin, Theodore Robert Levin, Finlay Macrae, Gerrit A. Meijer, Joshua Melson, Colm O'Morain, Susan Parry, Linda Rabeneck, David F. Ransohoff, Roque Saenz, Hiroshi Saito, Silvia Sanduleanu-Dascalescu, Robert E. Schoen, Kevin Selby, Harminder Singh, Robert J. C. Steele, Joseph J. Y. Sung, Erin Leigh Symonds, Sidney J. Winawer

Summary: New non-invasive tests for colorectal cancer (CRC) are emerging, making it challenging to conduct trials with mortality reduction as the main goal. A formal consensus approach involving experts resulted in the revision of previously established principles and the emergence of twelve new principles. The effectiveness of a new test can be evaluated by comparing it with an established non-invasive test, with the faecal immunochemical test considered as the appropriate comparator. Flexible adjustment of the new test's positivity threshold is desirable to meet different screening goals and requirements. A four-phased approach is proposed for the evaluation of new tests, including small studies, prospective estimation of accuracy, evaluation in screening populations, and monitoring for missed lesions.
Article Public, Environmental & Occupational Health

Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland

Sarah Amele, Eliud Kibuchi, Ronan McCabe, Anna Pearce, Paul Henery, Kirsten Hainey, Adeniyi Francis Fagbamigbe, Amanj Kurdi, Colin McCowan, Colin R. Simpson, Chris Dibben, Duncan Buchanan, Evangelia Demou, Fatima Almaghrabi, Gina Anghelescu, Harry Taylor, Holly Tibble, Igor Rudan, James Nazroo, Laia Becares, Luke Daines, Patricia Irizar, Sandra Jayacodi, Serena Pattaro, Aziz Sheikh, Srinivasa Vittal Katikireddi

Summary: This study aimed to estimate ethnic inequalities in the risk of positive SARS-CoV-2 tests, COVID-19 hospitalizations, and deaths over time in Scotland. A population-based cohort study linking the 2011 Scottish Census to health records was conducted. The findings revealed that most ethnic minority groups in Scotland, especially White Gypsy/Traveller and Pakistani groups, were at higher risk of adverse COVID-19 outcomes. Ethnic inequalities persisted following community infection but did not exist after hospitalization, suggesting that differences in hospital treatment did not substantially contribute to ethnic inequalities.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2023)

Article Public, Environmental & Occupational Health

Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality

Gavin R. C. Clark, Thomas Godfrey, Calum Purdie, Judith Strachan, Francis A. Carey, Callum G. Fraser, Robert J. C. Steele

Summary: This study compared the interval cancer proportions between the FIT-based Scottish Bowel Screening Programme and the former gFOBT-based program, and investigated the associations between interval cancer and factors such as faecal haemoglobin concentration, sex, age, deprivation, site, and stage. The results showed that FIT had a higher proportion of screen detected cancers compared to interval cancers, and women had a higher proportion of interval cancers than men. Lowering the faecal haemoglobin threshold could reduce the number of interval cancers, but additional colonoscopy would be required.

JOURNAL OF MEDICAL SCREENING (2023)

No Data Available